Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of Nominated Adviser and Sole Broker

17th Jun 2025 07:00

RNS Number : 0755N
essensys PLC
17 June 2025
 

17 June 2025

essensys plc

Appointment of Nominated Adviser and Sole Broker

essensys plc (AIM:ESYS), the leading global provider of software and technology to the flexible workspace industry, is pleased to announce the appointment of Canaccord Genuity Limited as the Company's Nominated Adviser and Sole Broker, with immediate effect.

-Ends-

For further information, please contact:

essensys plc 

+44 (0)20 3102 5252

James Lowery, Chief Executive Officer 

Greg Price, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser and Broker) 

+44 (0)20 7523 8000 

Simon Bridges / Harry Gooden / Andrew Potts

 

Gracechurch Group 

Heather Armstrong / Alexis Gore / Rebecca Scott

+44 (0) 20 4582 3500

[email protected]

 

 

About essensys plc 

Founded in 2006 and listed on the London Stock Exchange AIM Market, essensys is a leading global provider of software and technology to the commercial real estate industry.

Partnering with many of the world's leading landlords and flexible workspace operators, essensys delivers innovative digital experience (DX) solutions that drive occupancy, maximise yield and reduce operating costs. Its flagship products, essensys Platform and elumo, solve the complex challenges of managing physical and digital access in dynamic multi-tenant environments, while delivering deep space utilisation insights and transformative digital experiences.

With a focus on Access, Intelligence & Experience, essensys' products enable real estate leaders to unlock the full potential of their portfolios in today's flexible, hybrid world while ensuring they stay ahead in an era of dynamic workplace evolution.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFMPTMTJBBAA

Related Shares:

Essensys
FTSE 100 Latest
Value8,774.65
Change-17.15